WASHINGTON, D.C.– Christopher W. Hansen, President of the American Cancer Society Cancer Action Network (ACS CAN), released this statement following Tuesday’s election:
A District Court judge is expected to hear oral arguments in Washington, D.C., from groups challenging a rule implementing changes to short-term insurance plans. The hearing will allow plaintiffs to explain the devastating impact patients could face if bare-bones plans are permitted to be sold for up to 36 months.
The administration released guidance today to give states expanded authority to offer less comprehensive plans to individuals who purchase their health insurance coverage through the individual market.
The Office of Management and Budget (OMB) has indicated it is reviewing a proposed rule from the Food and Drug Administration (FDA) that would modernize mammography quality standards and address breast density reporting to patients and health care providers.
The American Cancer Society Cancer Action Network (ACS CAN) released a publication today to illustrate health disparities across the cancer continuum and discuss public policy strategies to address those disparities. Cancer Disparities: A Chartbook illustrates the scope of cancer disparities that exist in the United States.
Today the U.S. Senate rejected a resolution under the Congressional Review Act that would have prevented the extension and expansion of short-term limited duration health insurance plans (STLD) as allowed under a new rule from the Departments of Health and Human Services (HHS) and Treasury.
Patient groups representing millions of Americans with serious health conditions filed an amicus curiae today in the U.S. District Court case, Association for Community Affiliated Plans v. United States Department of Treasury, explaining the devastating impact patients could face under the final rule implementing changes to short-term, limited duration (STLD) insurance plans.
Following negotiations between both chambers of Congress, a comprehensive and bipartisan legislative package to address the nation’s opioid epidemic now heads to the president’s desk for approval and enactment.
Today the U.S. House of Representatives passed a combined Defense and Labor, Health and Human Services (LHHS) bill that includes a $2 billion increase for medical research at the National Institutes of Health (NIH) and a total of $6.1 billion for the National Cancer Institute (NCI).
Today the U.S. Senate passed a combined Defense and Labor, Health and Human Services (LHHS) bill that includes a $2 billion increase for medical research at the National Institutes of Health (NIH) and a total of $6.1 billion for the National Cancer Institute (NCI).